Caricamento...
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis
Glioblastoma is a rare and aggressive primary brain tumor with incidence of 5 per 100,000 annually. We report a 50-year-old woman diagnosed with glioblastoma within 3 years of induction of fingolimod therapy for relapsing-remitting multiple sclerosis. Fingolimod, an immunomodulating agent used in th...
Salvato in:
| Pubblicato in: | J Clin Neurosci |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4925177/ https://ncbi.nlm.nih.gov/pubmed/26970935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocn.2016.02.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|